{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01909",
      "entity_text" : "Pembrolizumab",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5755",
      "entity_text" : "prednisolone",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Oral prednisolone induced remission, enabling continuation of Pembrolizumab.",
  "reading_complete" : "2020-08-03T12:29:21Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:29:11Z",
  "trigger" : "induced",
  "evidence" : [ "prednisolone induced remission, enabling continuation of Pembrolizumab" ],
  "pmc_id" : "6452463",
  "score" : 0
}